The Journal of Current Hematology & Oncology Research regularly publishes internationally qualified research in hematology and oncology within the current scholarly knowledge.
Published: 14 Nov 2024
Citation: Uzun D, Keklik M, Eser B. Shedding light on allogeneic hematopoietic stem cell transplantation success: exploring the relationship between donor vitamin D and parathormone levels and recipient engraftment and stem cell quantity. J Curr Hematol Oncol Res. 2024;2(4):79-82.
Published: 14 Nov 2024
Citation: Balık B, Mutlu YG, Sevindik ÖG. Myeloid differentiation primary response 88 expression in central nervous system lymphomas. J Curr Hematol Oncol Res. 2024;2(4):83-86.
Published: 14 Nov 2024
Citation: Yılmaz S, Günay A, Cırık S, Baştürk A, Başdemirci M, Balasar Ö. Diagnostic white blood cells can be a predictor for mutation existence in myelodisplastic syndromes: the role of next generation sequencing. J Curr Hematol Oncol Res. 2024;2(4):87-92.
Published: 14 Nov 2024
Citation: Tan T, Doğan ÖD, Civriz Bozdağ S. Can bispecific antibody therapies for multiple myeloma be a risk factor for the development of secondary haemotopoietic malignancy? A case report. J Curr Hematol Oncol Res. 2024; 2(4): 93-94.
Published: 14 Nov 2024
Citation: Çiftciler R, Çiftciler AE, Selim C, Çelik M. Kikuchi-Fujimoto disease: a rare cause of fever and lymphadenopathy in a 19-year-old male. J Curr Hematol Oncol Res. 2024;2(4): 95-97.
Published: 14 Nov 2024
Citation: Karatlı S, Kavak EE. A rare case of olfactory neuroblastoma. J Curr Hematol Oncol Res. 2024;2(4):98-99.
Published: 14 Nov 2024
Citation: Güven İE. The relationship between hepatocellular carcinoma and resolvin D1. J Curr Hematol Oncol Res. 2024;2(4):100.
Published: 30 Aug 2023
Citation: Barış Iİ, Büyükbayram H. ß-catenin expression in myelodysplastic syndromes and myeloproliferative neoplasms in bone marrow, in relation to CD34 and CD117 status. J Curr Hematol Oncol Res. 2023;1(3):54-58.
Published: 30 Aug 2023
Citation: Fidan K. Chronic lymphocytic leukemia. J Curr Hematol Oncol Res. 2023;1(3):59-67.
Published: 26 Feb 2023
Citation: Kaya A, Berber İ, Kuku İ, et al. Effect of tyrosine kinase inhibitor and conventional chemotherapy on COVID-19 antibody level in hematological patients. J Curr Hematol Oncol Res. 2023; 1(1): 1-4